Generate report
Danipharm A/S
Englandsvej 350-356, 2770 Kastrup, CVR 12335040
ad
More financial key figures and analyses?
In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!
Rank Profit for the year
Rank in industry
3/33
"Top 10%"
Rank in Denmark
15,728/336,950
"Top 10%"
Top management top 3
Peter Rørvig 5 | Director |
Board top 3
Niels Ulrik Heine 48 | Chairman of board |
Helle Rørvig 5 | Boardmember |
Peter Rørvig 5 | Boardmember |
Legal owners top 3
100% | H&P Rørvig Holding A/S | DK |
Rights certificate
Selskabet tegnes af en direktør eller af et bestyrelsesmedlem.
Company information based on CVR
Name | Danipharm A/S |
CVR | 12335040 |
Address | Englandsvej 350-356, 2770 Kastrup |
Industry | Manufacture of basic pharmaceutical products [211000] |
Established | 01-08-1988 (35 yr) |
First financial statement period | 01-08-1988 to 30-06-1989 |
Company type | Limited Corporation |
Number of employees | 29 (man years:30) |
Advertising protection | No |
Auditor | Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab since 01-07-2011 |
Financial statement period | 01-07 to 30-06 |
Company capital | 500,000 DKK 250,000 DKK (22-12-1988 - 20-11-1996) 80,000 DKK (01-08-1988 - 21-12-1988) |
Articles of assoc. last | 20-04-2023 |
Member of industries
- Manufacture of basic pharmaceutical productsNACE6 containing 38 comp.
- Manufacture of basic pharmaceutical productsNACE3 containing 38 comp.
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE2 containing 254 comp.
- ManufacturingNACE1 containing 26,560 comp.
Purpose
Selskabets formål er at drive handel, produktion og forskning
Financial Statement
2022 | 2021 | 2020 | |
---|---|---|---|
Currency/unit | 000' DKK | 000' DKK | 000' DKK |
Revenue | - - | - - | 91,597 - |
Gross Profit | 34,935 +19% | 29,395 -7% | 31,639 -26% |
Profit for the year | 8,191 +178% | 2,944 -49% | 5,767 -65% |
Equity | 36,059 +21% | 29,869 +11% | 26,924 +27% |
Total Assets | 78,307 +7% | 73,178 +6% | 68,942 +103% |